Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL28B polymorphisms and peginterferon alfa monotherapy outcome in acute hepatitis C among HIV-infected patients
NL-OMON34931Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of pegylated interferon alpha in hepatitis C virus infection, sponsored by University Medical Center Utrecht. Started Jun 2010; status: active, not recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON34931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34931.